 | • レポートコード：MRC2-11QY01127 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はB型肝炎ワクチンのグローバル市場について調査・分析したレポートです。種類別（モノワクチン、コンビネーションワクチン）市場規模、用途別（adr、adw、ayr、ayw）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別B型肝炎ワクチンの競争状況、市場シェア ・世界のB型肝炎ワクチン市場：種類別市場規模 2015年-2020年（モノワクチン、コンビネーションワクチン） ・世界のB型肝炎ワクチン市場：種類別市場規模予測 2021年-2026年（モノワクチン、コンビネーションワクチン） ・世界のB型肝炎ワクチン市場：用途別市場規模 2015年-2020年（adr、adw、ayr、ayw） ・世界のB型肝炎ワクチン市場：用途別市場規模予測 2021年-2026年（adr、adw、ayr、ayw） ・北米のB型肝炎ワクチン市場分析：米国、カナダ ・ヨーロッパのB型肝炎ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのB型肝炎ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のB型肝炎ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのB型肝炎ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck、Sanofi Pasteur、Dynavax Technologies、Janssen Pharmaceuticals、LG Life Sciences、KM Biologics、Shenzhen Kangtai Biological Products ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hepatitis B Vaccines Market
The global Hepatitis B Vaccines market size is projected to reach US$ 1646.3 million by 2026, from US$ 1597.1 million in 2020, at a CAGR of 2.8%% during 2021-2026.
Global Hepatitis B Vaccines Scope and Market Size
Hepatitis B Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hepatitis B Vaccines market is segmented into
Mono Vaccines
Combination Vaccines
Segment by Application, the Hepatitis B Vaccines market is segmented into
adr
adw
ayr
ayw
Regional and Country-level Analysis
The Hepatitis B Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hepatitis B Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hepatitis B Vaccines Market Share Analysis
Hepatitis B Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hepatitis B Vaccines business, the date to enter into the Hepatitis B Vaccines market, Hepatitis B Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck
Sanofi Pasteur
Dynavax Technologies
Janssen Pharmaceuticals
LG Life Sciences
KM Biologics
Shenzhen Kangtai Biological Products
1 Study Coverage
1.1 Hepatitis B Vaccines Product Introduction
1.2 Market Segments
1.3 Key Hepatitis B Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type
1.4.2 Mono Vaccines
1.4.3 Combination Vaccines
1.5 Market by Application
1.5.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application
1.5.2 adr
1.5.3 adw
1.5.4 ayr
1.5.5 ayw
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Hepatitis B Vaccines Revenue 2015-2026
2.1.2 Global Hepatitis B Vaccines Sales 2015-2026
2.2 Global Hepatitis B Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hepatitis B Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hepatitis B Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hepatitis B Vaccines Competitor Landscape by Players
3.1 Hepatitis B Vaccines Sales by Manufacturers
3.1.1 Hepatitis B Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Hepatitis B Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Hepatitis B Vaccines Revenue by Manufacturers
3.2.1 Hepatitis B Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Hepatitis B Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepatitis B Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Revenue in 2019
3.2.5 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hepatitis B Vaccines Price by Manufacturers
3.4 Hepatitis B Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis B Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis B Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis B Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis B Vaccines Market Size by Type (2015-2020)
4.1.1 Global Hepatitis B Vaccines Sales by Type (2015-2020)
4.1.2 Global Hepatitis B Vaccines Revenue by Type (2015-2020)
4.1.3 Hepatitis B Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hepatitis B Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Hepatitis B Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Hepatitis B Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Hepatitis B Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hepatitis B Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis B Vaccines Market Size by Application (2015-2020)
5.1.1 Global Hepatitis B Vaccines Sales by Application (2015-2020)
5.1.2 Global Hepatitis B Vaccines Revenue by Application (2015-2020)
5.1.3 Hepatitis B Vaccines Price by Application (2015-2020)
5.2 Hepatitis B Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Hepatitis B Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Hepatitis B Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepatitis B Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hepatitis B Vaccines by Country
6.1.1 North America Hepatitis B Vaccines Sales by Country
6.1.2 North America Hepatitis B Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hepatitis B Vaccines Market Facts & Figures by Type
6.3 North America Hepatitis B Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Hepatitis B Vaccines by Country
7.1.1 Europe Hepatitis B Vaccines Sales by Country
7.1.2 Europe Hepatitis B Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis B Vaccines Market Facts & Figures by Type
7.3 Europe Hepatitis B Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccines by Region
8.1.1 Asia Pacific Hepatitis B Vaccines Sales by Region
8.1.2 Asia Pacific Hepatitis B Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hepatitis B Vaccines by Country
9.1.1 Latin America Hepatitis B Vaccines Sales by Country
9.1.2 Latin America Hepatitis B Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hepatitis B Vaccines Market Facts & Figures by Type
9.3 Central & South America Hepatitis B Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccines by Country
10.1.1 Middle East and Africa Hepatitis B Vaccines Sales by Country
10.1.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Hepatitis B Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Hepatitis B Vaccines Products Offered
11.2.5 Merck Related Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Description and Business Overview
11.3.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Pasteur Hepatitis B Vaccines Products Offered
11.3.5 Sanofi Pasteur Related Developments
11.4 Dynavax Technologies
11.4.1 Dynavax Technologies Corporation Information
11.4.2 Dynavax Technologies Description and Business Overview
11.4.3 Dynavax Technologies Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dynavax Technologies Hepatitis B Vaccines Products Offered
11.4.5 Dynavax Technologies Related Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Corporation Information
11.5.2 Janssen Pharmaceuticals Description and Business Overview
11.5.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Janssen Pharmaceuticals Hepatitis B Vaccines Products Offered
11.5.5 Janssen Pharmaceuticals Related Developments
11.6 LG Life Sciences
11.6.1 LG Life Sciences Corporation Information
11.6.2 LG Life Sciences Description and Business Overview
11.6.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.6.4 LG Life Sciences Hepatitis B Vaccines Products Offered
11.6.5 LG Life Sciences Related Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Description and Business Overview
11.7.3 KM Biologics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 KM Biologics Hepatitis B Vaccines Products Offered
11.7.5 KM Biologics Related Developments
11.8 Shenzhen Kangtai Biological Products
11.8.1 Shenzhen Kangtai Biological Products Corporation Information
11.8.2 Shenzhen Kangtai Biological Products Description and Business Overview
11.8.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccines Products Offered
11.8.5 Shenzhen Kangtai Biological Products Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Hepatitis B Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hepatitis B Vaccines Market Estimates and Projections by Region
12.1.1 Global Hepatitis B Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Hepatitis B Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Hepatitis B Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Hepatitis B Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Hepatitis B Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Hepatitis B Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Hepatitis B Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Hepatitis B Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Hepatitis B Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Hepatitis B Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hepatitis B Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hepatitis B Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hepatitis B Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hepatitis B Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Hepatitis B Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Hepatitis B Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Hepatitis B Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Hepatitis B Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hepatitis B Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hepatitis B Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hepatitis B Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hepatitis B Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hepatitis B Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis B Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hepatitis B Vaccines Market Segments
Table 2. Ranking of Global Top Hepatitis B Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepatitis B Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Mono Vaccines
Table 5. Major Manufacturers of Combination Vaccines
Table 6. Global Hepatitis B Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Hepatitis B Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Hepatitis B Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Hepatitis B Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Hepatitis B Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Hepatitis B Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Hepatitis B Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Hepatitis B Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccines as of 2019)
Table 15. Hepatitis B Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Hepatitis B Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Hepatitis B Vaccines Price (2015-2020) (USD/Unit)
Table 18. Hepatitis B Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Hepatitis B Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Hepatitis B Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Hepatitis B Vaccines Sales Share by Type (2015-2020)
Table 24. Global Hepatitis B Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Hepatitis B Vaccines Revenue Share by Type (2015-2020)
Table 26. Hepatitis B Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Hepatitis B Vaccines Sales Share by Application (2015-2020)
Table 29. North America Hepatitis B Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Hepatitis B Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Hepatitis B Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Hepatitis B Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Hepatitis B Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Hepatitis B Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Hepatitis B Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Hepatitis B Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Hepatitis B Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Hepatitis B Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Hepatitis B Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Hepatitis B Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Hepatitis B Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Hepatitis B Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Hepatitis B Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Hepatitis B Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Major Businesses
Table 71. GlaxoSmithKline Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline Product
Table 73. GlaxoSmithKline Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Sanofi Pasteur Corporation Information
Table 80. Sanofi Pasteur Description and Major Businesses
Table 81. Sanofi Pasteur Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Sanofi Pasteur Product
Table 83. Sanofi Pasteur Recent Development
Table 84. Dynavax Technologies Corporation Information
Table 85. Dynavax Technologies Description and Major Businesses
Table 86. Dynavax Technologies Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Dynavax Technologies Product
Table 88. Dynavax Technologies Recent Development
Table 89. Janssen Pharmaceuticals Corporation Information
Table 90. Janssen Pharmaceuticals Description and Major Businesses
Table 91. Janssen Pharmaceuticals Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Janssen Pharmaceuticals Product
Table 93. Janssen Pharmaceuticals Recent Development
Table 94. LG Life Sciences Corporation Information
Table 95. LG Life Sciences Description and Major Businesses
Table 96. LG Life Sciences Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. LG Life Sciences Product
Table 98. LG Life Sciences Recent Development
Table 99. KM Biologics Corporation Information
Table 100. KM Biologics Description and Major Businesses
Table 101. KM Biologics Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. KM Biologics Product
Table 103. KM Biologics Recent Development
Table 104. Shenzhen Kangtai Biological Products Corporation Information
Table 105. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 106. Shenzhen Kangtai Biological Products Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Shenzhen Kangtai Biological Products Product
Table 108. Shenzhen Kangtai Biological Products Recent Development
Table 109. Global Hepatitis B Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 110. Global Hepatitis B Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Hepatitis B Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Hepatitis B Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Hepatitis B Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 114. North America: Hepatitis B Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Hepatitis B Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 116. Europe: Hepatitis B Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Hepatitis B Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 118. Asia Pacific: Hepatitis B Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Hepatitis B Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 120. Latin America: Hepatitis B Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Hepatitis B Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 122. Middle East and Africa: Hepatitis B Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Hepatitis B Vaccines Players
Table 127. Hepatitis B Vaccines Customers List
Table 128. Hepatitis B Vaccines Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Vaccines Product Picture
Figure 2. Global Hepatitis B Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Mono Vaccines Product Picture
Figure 4. Combination Vaccines Product Picture
Figure 5. Global Hepatitis B Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. adr
Figure 7. adw
Figure 8. ayr
Figure 9. ayw
Figure 10. Hepatitis B Vaccines Report Years Considered
Figure 11. Global Hepatitis B Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Hepatitis B Vaccines Sales 2015-2026 (K Units)
Figure 13. Global Hepatitis B Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Hepatitis B Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Hepatitis B Vaccines Sales Market Share by Region in 2019
Figure 16. Global Hepatitis B Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Hepatitis B Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Hepatitis B Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Hepatitis B Vaccines Revenue in 2019
Figure 20. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Hepatitis B Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Hepatitis B Vaccines Sales Market Share by Type in 2019
Figure 23. Global Hepatitis B Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Hepatitis B Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Hepatitis B Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Hepatitis B Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Hepatitis B Vaccines Sales Market Share by Application in 2019
Figure 28. Global Hepatitis B Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Hepatitis B Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Hepatitis B Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Hepatitis B Vaccines Sales Market Share by Country in 2019
Figure 33. North America Hepatitis B Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Hepatitis B Vaccines Market Share by Type in 2019
Figure 39. North America Hepatitis B Vaccines Market Share by Application in 2019
Figure 40. Europe Hepatitis B Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Hepatitis B Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Hepatitis B Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Hepatitis B Vaccines Market Share by Type in 2019
Figure 55. Europe Hepatitis B Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Hepatitis B Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region in 2019
Figure 60. China Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Hepatitis B Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Hepatitis B Vaccines Market Share by Application in 2019
Figure 84. Latin America Hepatitis B Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Hepatitis B Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Hepatitis B Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Hepatitis B Vaccines Market Share by Type in 2019
Figure 95. Latin America Hepatitis B Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Hepatitis B Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Hepatitis B Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Hepatitis B Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Hepatitis B Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Hepatitis B Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Hepatitis B Vaccines Market Share by Application in 2019
Figure 108. North America Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Hepatitis B Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Hepatitis B Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…- ヒト用混合ワクチンの世界市場（～2026年） A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are eith…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…